Health Catalyst (HCAT)

• Market cap: $311M
• 1 day: 6.24%
• 5 days: 1.14%
• 1 month: -18.57%
• 3 months: -44.69%
• 6 months: -44.76%
• Year to date: -39.65%
• 1 year: -45.64%
• 5 years: -81.91%
• 10 years: -88.69%
• Sector: Information Technology
• Industry: Computer Programming, Data Processing, Etc.

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,500

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

18,317% more call options, than puts

Call options by funds: $21M | Put options by funds: $114K

40% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 20

25% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 48

4% more funds holding

Funds holding: 159 [Q3] → 165 (+6) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

3.0% less ownership

Funds ownership: 88.2% [Q3] → 85.2% (-3.0%) [Q4]

13% less capital invested

Capital invested by funds: $434M [Q3] → $376M (-$57.9M) [Q4]

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $5 13% upside
• Avg. target: $7.88 78% upside
• High target: $10 126% upside

8 analyst ratings

• positive: 5 63%
• neutral: 3 38%
• negative: 0 0%

Stephens & Co. Jeff Garro 50% 1-year accuracy 6 / 12 met price target	13% upside $5	Equal-Weight Maintained	6 Mar 2025
RBC Capital Sean Dodge 38% 1-year accuracy 14 / 37 met price target	35% upside $6	Sector Perform Maintained	27 Feb 2025
Stifel David Grossman 43% 1-year accuracy 10 / 23 met price target	13% upside $5	Hold Maintained	27 Feb 2025
Piper Sandler Jessica Tassan 29% 1-year accuracy 7 / 24 met price target	81% upside $8	Overweight Maintained	11 Feb 2025
Wells Fargo Stan Berenshteyn 30% 1-year accuracy 3 / 10 met price target	126% upside $10	Overweight Maintained	21 Jan 2025